Retina Group of New England | ClinicalTrials HQ

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME	diabetic macular edema	Active, not recruiting	Phase 3	2026-10-08		NCT04108156
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration	Neovascular Age-related Macular Degeneration; nAMD	Recruiting	Phase 3	2026-09-29		NCT07614776
Extension Study for the Port Delivery System With Ranibizumab (Portal)	Neovascular Age-Related Macular Degeneration	Recruiting	Phase 3	2026-09-28		NCT03683251
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy	Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder	Recruiting	Phase 3	2026-09-18		NCT06541704
A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)	diabetic macular edema	Active, not recruiting	Phase 3	2026-09-18		NCT06491914
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD	Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder	Recruiting	Phase 2	2026-09-10		NCT06659445
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)	Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration	Recruiting	Phase 2 / Phase 3	2026-08-06		NCT07496567
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study	Neovascular Age-Related Macular Degeneration (nAMD)	Recruiting	Phase 3	2026-07-01		NCT07516132
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration	Neovascular Age-related Macular Degeneration	Active, not recruiting	Phase 3	2025-06-17		NCT06495918